scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1046008149 |
P356 | DOI | 10.1186/1478-7547-12-3 |
P932 | PMC publication ID | 3904011 |
P698 | PubMed publication ID | 24450591 |
P5875 | ResearchGate publication ID | 259875433 |
P50 | author | Maarten J. Postma | Q87840199 |
Desmond Curran | Q53403841 | ||
P2093 | author name string | Baudouin A Standaert | |
P2860 | cites work | Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants | Q57530944 |
The need for an evidence-based decision-making process with regard to control of hepatitis A | Q82218107 | ||
Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclusions and recommendations | Q84008463 | ||
Factors influencing immunisation coverage in Mathare Valley, Nairobi | Q84294933 | ||
Economic evaluation of second generation pneumococcal conjugate vaccines in Norway | Q84980530 | ||
Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed data | Q30000818 | ||
The effect of rotavirus vaccine on diarrhoea mortality | Q33754470 | ||
Maintaining vaccine delivery following the introduction of the rotavirus and pneumococcal vaccines in Thailand | Q34023894 | ||
Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. | Q34285208 | ||
Understanding reduced rotavirus vaccine efficacy in low socio-economic settings | Q34374045 | ||
Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. | Q36291026 | ||
The impact of making vaccines thermostable in Niger's vaccine supply chain | Q36670247 | ||
Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial | Q37695264 | ||
Rotarix®: vaccine performance 6 years postlicensure | Q37956376 | ||
Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality | Q37981766 | ||
Rotavirus vaccines in developing countries: the potential impact, implementation challenges, and remaining questions | Q38004112 | ||
Rotavirus vaccination: a concise review | Q38033657 | ||
Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate | Q38061747 | ||
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial | Q39944921 | ||
Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. | Q46390356 | ||
Rotavirus vaccine--a powerful tool to combat deaths from diarrhea | Q46777043 | ||
Immunogenicity of the pentavalent rotavirus vaccine in African infants | Q47832209 | ||
Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program | Q48030944 | ||
Determinants of vaccination coverage for children and teenagers | Q48131658 | ||
Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada. | Q50724131 | ||
Integer/linear mathematical programming models: a tool for allocating healthcare resources. | Q52011177 | ||
Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States. | Q53392521 | ||
P433 | issue | 1 | |
P921 | main subject | mathematical modelling | Q10331368 |
P304 | page(s) | 3 | |
P577 | publication date | 2014-01-22 | |
P1433 | published in | Cost Effectiveness and Resource Allocation | Q15757606 |
P1476 | title | Budget constraint and vaccine dosing: a mathematical modelling exercise | |
P478 | volume | 12 |
Q54989442 | 2. How is the economic assessment of vaccines performed today? |
Q54963976 | 3. How comprehensive can we be in the economic assessment of vaccines? |
Q51773551 | Challenges in adult vaccination. |
Q90013854 | How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future |
Q47437649 | Improving the Hospital Quality of Care during Winter Periods by Optimizing Budget Allocation Between Rotavirus Vaccination and Bed Expansion |
Q36914109 | Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? |
Q40521168 | Vaccine impact: Benefits for human health |
Search more.